Depressive Disorder Clinical Trial
Official title:
Evaluation of a Guideline-based Net Care Intervention to Reduce the Duration of Inpatient Depression Treatment
The cost-effectiveness of a new, guideline oriented sequential inpatient - outpatient treatment model will be investigated. Secondary outcomes are: patient satisfaction, practitioners' satisfaction and influence on work.
Great diversity concerning duration of inpatient treatment of depression in
psychiatric-psychotherapeutic hospitals is often used as an argument for the possible
reduction of length of stay. Yet shorter duration of inpatient treatment of depressive
episodes has not been examined systematically concerning clinical outcomes and health
economic consequences. In this study the cost-effectiveness of a new sequential
inpatient-outpatient treatment model will be examined. The research hypothesis is that the
new treatment model will be more cost-effective than treatment as usual. The design provides
a randomized controlled trial (RCT) in four psychiatric-psychotherapeutic clinics with a
total of 240 patients. First medical practitioners and psychologist will receive a
retraining concerning guideline-based care and the new treatment model will be implemented
in the hospitals. New patients admitted to one of the hospitals will then be assigned
randomly to one of the two study conditions und prospectively examined at five measuring
times: Condition A (control group) contains treatment as usual (individual treatment
programme, discharge after remission), Condition B (intervention group) contains the
sequential inpatient-outpatient treatment (guideline-based treatment, discharge after partly
remission: BDI <20, outpatient treatment in the hospital and guided transfer to outpatient
care).
Primary outcome is the reduction of costs of treatment in relation to reduction of symptoms.
Secondary outcomes will be reduction of the depressive pathology as well as the extent of
satisfaction among patients and practitioners. A total of 240 patients will be examined from
admission until 12 month after discharge. Both information from the patients and the
practitioners will be charged with well implemented and established instruments (psychiatric
basic documentation system, BADO). A specific questionnaire will be used to measure the
practitioners` satisfaction and the consequences of the sequential inpatient-outpatient
treatment. To answer the main question about the cost-effectiveness analyses of central
health economic outcome variables (direct and indirect costs of treatment) will be
performed. This study is going to give differentiated and scientific evidence of the
efficiency of a new sequential inpatient-outpatient treatment for depressive disorders. The
participation of psychiatric-psychotherapeutic hospitals with different functions and
structures in the public health care systems (academic medical centre, psychiatric
department of general hospital, psychiatric centres) enable the evaluation of the new
treatment model under diverse structural and organizational conditions.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01316926 -
Paxil CR Bioequivalence Study Brazil
|
Phase 1 | |
| Recruiting |
NCT06187454 -
Transcranial Direct Current Stimulation for Depression
|
N/A | |
| Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
| Recruiting |
NCT05768126 -
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
|
Phase 4 | |
| Completed |
NCT03219879 -
Telephone-administered Relapse Prevention for Depression
|
N/A | |
| Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
| Completed |
NCT03043560 -
Study to Treat Major Depressive Disorder With a New Medication
|
Phase 2 | |
| Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
| Completed |
NCT00069459 -
Seasonal Affective Depression (SAD) Study
|
Phase 1 | |
| Recruiting |
NCT05503966 -
Combining Antidepressants and Attention Bias Modification in Depression
|
N/A | |
| Recruiting |
NCT03001245 -
Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents
|
N/A | |
| Completed |
NCT02939560 -
TMS for Adults With Autism and Depression
|
N/A | |
| Completed |
NCT02542891 -
European Comparative Effectiveness Research on Internet-based Depression Treatment
|
N/A | |
| Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
| Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
| Completed |
NCT02306551 -
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
|
||
| Withdrawn |
NCT02238730 -
Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy
|
N/A | |
| Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
| Completed |
NCT01597661 -
Bupropion & Cardio Birth Defect (Slone)
|
N/A | |
| Completed |
NCT01093053 -
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
|
N/A |